natgillin/translations-raw huggingface dataset:
Ciprofloxacin Bayer 100 mg film-coated tablets are indicated for the treatment of the following infections (see sections 4.4 and 5.1). 
Zdravilo Ciprofloksacin Bayer 100 mg filmsko obložene tablete se uporablja za zdravljenje naslednjih okužb (glejte poglavji 4.4 in 5.1).
At the first sign of any pain or inflammation Ciprofloxacin Bayer will have to be stopped, rest the painful area. 
Ob prvih znakih bolečine ali vnetja je treba zdravljenje z zdravilom Ciprofloksacin Bayer prekiniti.
Ciprofloxacin is present in the bile in high concentrations. 
Koncentracija ciprofloksacina v žolču je velika.
Treatment should be initiated only after a careful benefit/risk evaluation, due to possible adverse events related to joints and/or surrounding tissue. 
Zaradi možnih neželenih učinkov na sklepe in/ali sosednja tkiva, se zdravljenje lahko začne samo po skrbni oceni koristnosti zdravljenja in tveganja.
250 mg twice daily to 500 mg twice daily 
250 mg do 500 mg dvakrat na dan
• allergic (hypersensitive) to the active substance, to other quinolone drugs or to any of the other ingredients of Ciprofloxacin Bayer (see section 6) 
- ste alergični (preobčutljivi) za zdravilno učinkovino, druge kinolone ali katerokoli sestavino zdravila Ciprofloksacin Bayer (glejte poglavje 6) - jemljete zdravilo tizanidin (glejte poglavje 2: Jemanje drugih zdravil)
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING FLEXIBLE PO/PVC BAG (400 mg / 200 mL solution for infusion) 
PODATKI NA PRIMARNI OVOJNINI PO/PVC VREČE (400 mg/200 ml raztopine za infundiranje)
Increase in blood alkaline phosphatase 
− zvečane vrednosti alkalne fosfataze v krvi (posebna snov v krvi)
The most commonly reported adverse drug reactions (ADRs) are nausea and diarrhoea. 
Neželena učinka, o katerih so največkrat poročali, sta slabost in driska.
In such infections ciprofloxacin must be coadministered with other appropriate antibacterial agents. 
V teh primerih je treba sočasno s ciprofloksacinom uporabiti tudi druga ustrezna antibakterijska zdravila.
With regards to the prophylaxis in neutropenic patients, the studies submitted by the Applicant/MAH showed comparable results between treatment groups. 
Predlagatelj/imetnik dovoljenja za promet z zdravilom je s predloženimi študijami ustrezno dokazal primerljivost rezultatov med zdravljenimi skupinami v zvezi s profilakso pri bolnikih z nevtropenijo.
HOW TO STORE CIPROFLOXACIN BAYER [To be completed nationally] 
SHRANJEVANJE ZDRAVILA CIPROFLOKSACIN BAYER [Izpolni država članica]
CIPROXIN 250 mg oral suspension oral use 
CIPROXIN 250 mg peroralna suspenzija peroralna uporaba
Inhalation anthrax post-exposure prophylaxis and curative treatment for persons requiring parenteral treatment Drug administration should begin as soon as possible after suspected or confirmed exposure. 
10 do 21 dni inhalacijski vranični prisad (zaščita in zdravljenje po izpostavitvi povzročitelju) pri osebah, ki potrebujejo parenteralno zdravljenje; zdravljenje je treba začeti takoj po domnevni ali potrjeni izpostavitvi povzročitelju
Neisseria gonorrhoeae* Proteus mirabilis* 
Klebsiella pneumoniae* Morganella morganii * Neisseria gonorrhoeae* Proteus mirabilis *
After intravenous initiation of treatment, the treatment can be switched to oral treatment with tablet or suspension if clinically indicated at the discretion of the physician. 
Če je klinično indicirano, se po presoji zdravnika, lahko začetno intravensko zdravljenje, nadaljuje s peroralnimi oblikami (s tabletami ali suspenzijo).
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING FLEXIBLE PO/PVC BAG (200 mg / 100 mL solution for infusion) 
PODATKI NA PRIMARNI OVOJNINI PO/PVC VREČE (200 mg/100 ml raztopine za infundiranje)
Ciprobay United Kingdom: Ciproxin 
Ciprobay Velika Britanija: Ciproxin
EUCAST Recommendations 
EUCAST (The European Committee on Antimicrobial Succeptibility Testing) priporočila
What Ciprofloxacin Bayer looks like and contents of the pack Film-coated tablet [To be completed nationally] 
Izgled zdravila Ciprofloksacin Bayer in vsebina pakiranja filmsko obložena tableta [Izpolni država članica]
500 mg twice daily to 750 mg twice daily 
500 mg do 750 mg dvakrat na dan
Hepatic impairment Cholestatic icterus Hepatitis 
− motnje v delovanju jeter, zlatenica (holestatski ikterus), hepatitis
• Your skin becomes more sensitive to sunlight or ultraviolet (UV) light when taking Ciprofloxacin Bayer. 
− Med zdravljenjem z zdravilom Ciprofloksacin Bayer lahko postane koža bolj občutljiva za sončno svetlobo ali ultravijolično sevanje (UV).
7.5 mL twice daily (one and a half 5-mL measuring spoonfuls twice daily) 
7,5 ml dvakrat na dan (ena in pol 5-ml merilna žlička dvakrat na dan)
If you stop taking Ciprofloxacin Bayer 
Če ste prenehali jemati zdravilo Ciprofloksacin Bayer
Bayer) - allergic reaction, allergic swelling (oedema), rapid swelling of the skin and mucous membranes 
− alergijska reakcija, alergijsko otekanje (edem) ali hitro otekanje kože in sluznic (angioedem),
CIPROXIN 250 mg/5 ml oral suspension oral use 
CIPROXIN 250 mg/5 ml peroralna suspenzija peroralna uporaba
• Tell the doctor or laboratory staff that you are taking Ciprofloxacin Bayer if you have to provide a blood or urine sample. 
− Če morate dati vzorec krvi ali seča za laboratorijske preiskave, obvestite svojega zdravnika ali laboratorijsko osebje, da jemljete zdravilo Ciprofloksacin Bayer.
Dyspnoea (including asthmatic condition) 
− lidokaina (lokalni anestetik)
Non-species-related breakpoints* 
Mejne vrednosti za nespecifične vrste
dosages schedules duration of treatment 
− trajanje zdravljenja.
In pre-menopausal women, 500 mg single dose may be used corresponding to 10 mL single dose = two 5-mL measuring spoonfuls as a single dose 
Pri ženskah v premenopavzi se lahko uporabi 500 mg enkrat na dan (ustreza 10 ml enkrat na dan = dve 5-ml merilni žlički enkrat na dan)
What Ciprofloxacin Bayer contains [To be completed nationally] 
Kaj vsebuje zdravilo Ciprofloksacin Bayer [Izpolni država članica]
Infections of the skin and soft tissue 
5 do 14 dni okužbe kože in mehkih tkiv
• skin and soft tissue infections 
• okužbe kože in mehkih tkiv z Gram negativnimi bakterijami
With regards to inhalation, intestinal and cutaneous anthrax, EMEA proposed guidelines in 2002 including the recommended use of ciprofloxacin in a first line treatment. 
Evropska agencija za zdravila je v letu 2002 sprejela smernice, ki pri vdihavanju, okužbi prebavil ali kože z antraksom priporočajo uporabo ciprofloksacina kot primarnega zdravljenja.
Cases of hepatic necrosis and life-threatening hepatic failure have been reported with ciprofloxacin (see section 4.8). 
Pri zdravljenju s ciprofloksacinom so poročali o primerih jetrne nekroze in življenjsko nevarne jetrne okvare (glejte poglavje 4.8).
• anthrax inhalation exposure 
izpostavljenosti Bacillus anthracis
CIPROXIN 500 mg oral suspension oral use 
CIPROXIN 500 mg peroralna suspenzija peroralna uporaba
Tablets are to be swallowed unchewed with fluid. 
Tablete se zaužije cele, z nekaj tekočine, ne glede na obroke hrane.
In pre-menopausal women, 500 mg single dose may be used corresponding to 5 mL single dose = one 5-mL measuring spoonful as a single dose 
Pri ženskah v premenopavzi se lahko uporabi 500 mg enkrat na dan (ustreza 5 ml enkrat na dan = ena 5-ml merilna žlička enkrat na dan)
NAME OF THE MARKETING AUTHORISATION HOLDER [To be completed nationally] {Name} 
IME IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM [Izpolni država članica] {Ime}
urinary tract inflammation - excessive sweating - abnormal levels of a clotting factor (prothromibin) increased levels of the enzyme amylase 
− nenormalne vrednosti faktorja strjevanja krvi (protrombin), zvečane vrednosti encima amilaza
Daily dose in mg and in mL 
Otroci in mladostniki indikacije dnevni odmerki (mg in ml)
The following undesirable effects have a higher frequency category in the subgroups of patients receiving intravenous or sequential (intravenous to oral) treatment: 
V podskupini bolnikov, ki so se zdravili intravensko ali sekvenčno (intravensko, nato peroralno), so se pogosteje pojavili naslednji neželeni učinki:
CIPROXIN 500 mg/5 ml oral suspension oral use 
CIPROXIN 500 mg/5 ml peroralna suspenzija peroralna uporaba
10 mg/kg body weight three times a day with a maximum of 400 mg per dose. 
10 mg/kg telesne mase trikrat na dan; največ 400 mg na odmerek
• Pelvic inflammatory disease including cases due to Neisseria gonorrhoeae 
• bolezni vnetja medenice vključno s primeri zaradi bakterije Neisseria gonorrhoeae
Ciprofloxacin should be used with caution in patients with CNS disorders which may be predisposed to seizure. 
Pri bolnikih z motnjami osrednjega živčevja, ki so nagnjeni h pojavljanju krčev je treba ciprofloksacin uporabljati previdno.
COMMONLY SUSCEPTIBLE SPECIES 
Preobčutljivostne reakcije
However, do not take Ciprofloxacin Bayer suspension with dairy products such as milk or yoghurt or with fortified fruit-juice (e.g. calcium-fortified orange-juice). 
Ne jemljite peroralne suspenzije Ciprofloksacin Bayer hkrati z mlečnimi izdelki (npr. mleko, jogurt) ali s pijačami, obogatenimi z z minerali (npr. s kalcijem obogaten pomarančni sok).
Take special care with Ciprofloxacin Bayer 
Bodite posebno pozorni pri jemanju zdravila Ciprofloksacin Bayer
Petechiae Erythema multiforme Erythema nodosum StevensJohnson syndrome (potentially lifethreatening) 
petehije Erythema multiforme minor Erythema nodosum Stevens
IV treatment should be followed by oral route as soon as possible. 
Takoj ko je možno, je treba z intravenskega zdravljenja preiti na uporabo peroralnih oblik.
Two -month treatment duration in adults with oral ciprofloxacin given at the following dose, 500 mg bid, is considered as effective to prevent anthrax infection in humans. 
Dvomesečno zdravljenje s peroralnimi oblikami ciprofloksacina pri ljudeh v odmerkih 500 mg dvakrat na dan, naj bi bila učinkovita zaščita pred okužbo z vraničnim prisadom pri ljudeh.
• Complicated urinary tract infections and pyelonephritis 
• zapletene okužbe sečil in pielonefritis
Section 2: Take special care with Ciprofloxacin Bayer) - changes to the blood count (leukopenia, leukocytosis, neutropenia, anaemia), a drop in the number of red and white blood cells and platelets (pancytopenia), which may be fatal, bone marrow depression which may also be fatal (see Section 2: Take special care with Ciprofloxacin 
− spremembe v krvni sliki (levkopenija, levkocitoza, nevtropenija, anemija), zmanjšanje števila rdečih in belih krvnih celic in krvnih ploščic (pancitopenija), ki je lahko smrtno nevarna; depresija kostnega mozga, ki je tudi lahko smrtno nevarna (glejte poglavje 2, Bodite posebno pozorni pri uporabi zdravila Ciprofloksacin Bayer)
• respiratory tract infections 
• notranje okužbe trebuha
10 mg/kg body weight twice daily to 20 mg/kg body weight twice daily with a maximum of 750 mg per dose. 
10 mg/kg do 20 mg/kg telesne mase dvakrat na dan; največ 750 mg na odmerek
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (containing 1 bottle of 100 mg / 50 mL solution for infusion) 
PODATKI NA ZUNANJI OVOJNINI ŠKATLA (vsebuje 1 steklenico s 100 mg/50 ml raztopine za infundiranje)
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (containing 5 boxes with bottles of 50 mL solution for infusion) 
PODATKI NA ZUNANJI OVOJNINI ŠKATLA (vsebuje 5 škatel s steklenico s 50 ml raztopine za infundiranje)
100 mg/ml oral suspension oral use 
100 mg/ml peroralna suspenzija peroralna uporaba
The 400 mg intravenous dose administered over 60 minutes every 12 hours resulted in a Cmax similar to that observed with a 750 mg oral dose. 
uporabi 400 mg ciprofloksacina v 60 minutah na vsakih 12 ur podobna kot pri peroralni uporabi odmerka 750 mg.
Pasteurella spp. 
Pasturella spp.
10 g/100 ml oral suspension oral use 
10 g/100 ml peroralna suspenzija peroralna uporaba
20 mg/kg body weight twice daily with a maximum of 750 mg per dose. 
20 mg/kg telesne mase dvakrat na dan; največ 750 mg na odmerek
5 g/100 ml oral suspension oral use 
5 g/100 ml peroralna suspenzija peroralna uporaba
Ciprofloxacin Bayer may make you feel less alert. 
Zdravilo Ciprofloksacin Bayer lahko zmanjša odzivnost.
CIPROBAY 750 mg film-coated tablets oral use 
CIPROBAY 750 mg filmsko obložene tablete peroralna uporaba
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (containing 1 bottle of 400 mg /200 mL solution for infusion) 
PODATKI NA ZUNANJI OVOJNINI ŠKATLA (vsebuje 1 steklenico z 400 mg/200 ml raztopine za infundiranje)
Confusion and disorientation Anxiety reaction Abnormal dreams Depression Hallucinations 
− zmedenost, dezorientiranost, anksioznost, nočne more, depresija, halucinacije
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (containing 5 boxes with bottles of 200 mL solution for infusion) 
PODATKI NA ZUNANJI OVOJNINI ŠKATLA (vsebuje 5 škatel s steklenico z 200 ml raztopine za infundiranje)
Headache Dizziness Sleep disorders Taste disorders 
− glavobol, omotica, motnje spanja ali motnje okusa
Probenecid interferes with renal secretion of ciprofloxacin. 
Probenecid ovira izločanje ciprofloksacina skozi ledvice.
CIPROXIN 750 mg film-coated tablets oral use 
CIPROXIN 750 mg filmsko obložene tablete peroralna uporaba
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION [To be completed nationally.] 
DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET {MM/LLLL} [Izpolni država članica]
Geriatric patients should receive a dose selected according to the severity of the infection and the patient's creatinine clearance. 
Starejšim bolnikom se daje glede na resnost bolezni in očistek kreatinina najmanjši možni odmerek zdravila.
What Ciprofloxacin Bayer looks like and contents of the pack Solution for infusion [To be completed nationally] 
Izgled zdravila Ciprofloksacin Bayer in vsebina pakiranja raztopina za infundiranje [Izpolni država članica]
CIPROBAY 500 mg film-coated tablets oral use 
CIPROBAY 500 mg filmsko obložene tablete peroralna uporaba
CIPROBAY 250 mg film-coated tablets oral use 
CIPROBAY 250 mg filmsko obložene tablete peroralna uporaba
Marketing Authorisation Holder and Manufacturer [See Annex I - To be completed nationally] 
ŠTEVILKA(E) DOVOLJENJA (DOVOLJENJ) ZA PROMET [Glejte Dodatek I - Izpolni država članica]
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (containing 1 bottle of 200 mg / 100 mL solution for infusion) 
PODATKI NA ZUNANJI OVOJNINI ŠKATLA (vsebuje 1 steklenico z 200 mg/100 ml raztopine za infundiranje)
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (containing wraps with bags of 200 mL solution for infusion) 
PODATKI NA ZUNANJI OVOJNINI ŠKATLA (vsebuje omote z vrečami z 200 ml raztopine za infundiranje)
Inhalation anthrax post-exposure prophylaxis and curative treatment for persons able to receive treatment by oral route when clinically appropriate. 
inhalacijski vranični prisad (zaščita in zdravljenje po izpostavitvi povzročitelju) pri osebah, ki se lahko zdravijo peroralno, če je to klinično primerno; zdravljenje je treba začeti takoj po domnevni ali potrjeni izpostavitvi povzročitelju.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (containing wraps with bags of 100 mL solution for infusion) 
PODATKI NA ZUNANJI OVOJNINI ŠKATLA (vsebuje omote z vrečami s 100 ml raztopine za infundiranje)
PHARMACEUTICAL FORM Granules and solvent for oral suspension [To be completed nationally] 
FARMACEVTSKA OBLIKA zrnca in vehikel za peroralno suspenzijo [Izpolni država članica]
SPC Section 4.2 Posology and method of administration 
Povzetek glavnih značilnosti zdravila, poglavje 4.2: Odmerjanje in način uporabe
Monitoring of ropinirole-related side effects and dose adjustment as appropriate is recommended during and shortly after co-administration with ciprofloxacin (see section 
Priporoča se klinično spremljanje bolnika glede neželenih učinkov in ustrezna prilagoditev odmerkov ropinirola med zdravljenjem s ciprofloksacinom in po koncu zdravljenja s ciprofloksacinom (glejte poglavje 4.4).
Empty the bottle containing the granules for oral suspension into the opening of the bottle of solvent. 
Stresite zrnca za peroralno suspenzijo iz stekleničke v plastenko, ki vsebuje vehikel.
Toxic epidermal necrolysis (potentially lifethreatening) 
StevensJohnsonov sindrom (lahko smrtno nevaren) toksična epidermalna nekroliza (lahko smrtno nevarna)
Photosensitivity reactions (see section 4.4) 
kože in podkožja srbenje koprivnica reakcije (glejte poglavje 4.4)
Unless compatibility with other infusion solutions/drugs has been confirmed, the infusion solution must always be administered separately. 
Raztopino za infundiranje je treba vedno dati ločeno, razen če je bilo dokazano, da je kompatibilna z drugimi raztopinami za infundiranje/zdravili.
- muscle pain, inflammation of the joints, increased muscle tone, cramping, tendon ruptureespecially of the large tendon at the back of the ankle (Achilles tendon) (see Section 2: Take special care with Ciprofloxacin Bayer) - blood or crystals in the urine (see Section 2: Take special care with Ciprofloxacin Bayer), urinary tract inflammation - excessive sweating - abnormal levels of a clotting factor (prothromibin) increased levels of the enzyme amylase 
− mišične bolečine, vnetje sklepov, povečan tonus mišic, krči, raztrganje tetiv - posebno dolge tetive na zadnji strani gležnja (Ahilova tetiva) (glejte poglavje 2: Bodite posebno pozorni pri uporabi zdravila Ciprofloksacin Bayer)
Malignant external otitis 
maligno vnetje zunanjega ušesa
CIPROXIN 250 mg film-coated tablets oral use 
CIPROXIN 250 mg filmsko obložene tablete peroralna uporaba
• infections of the testicles 
• okužbe sečil
Glucose Load 
Vsebnost glukoze
10 mg/kg body weight twice daily to 20 mg/kg body weight twice daily with a maximum of 750 mg per dose, corresponding to a 0.1 mL/kg body weight twice daily to 0.2 mL/kg body weight twice daily with a maximum of 7.5 mL per dose 
10 mg/kg do 20 mg/kg telesne mase dvakrat na dan; največ 750 mg na odmerek kar odgovarja 0,1 ml/kg telesne mase dvakrat na dan do 0,2 ml/kg telesne mase dvakrat na dan; največ 7,5 ml na odmerek
What Ciprofloxacin Bayer looks like and contents of the pack Oral suspension (in single dose sachets) [To be completed nationally] 
Izgled zdravila Ciprofloksacin Bayer in vsebina pakiranja peroralna suspenzija, vrečice za enkratno uporabo [Izpolni država članica]
• complicated urinary tract infections, including infections that have reached the kidneys 
− zapletene okužbe sečil, vključno z okužbami ledvic (pielonefritis)
250 mg/5 ml oral suspension oral use 
250 mg/5 ml peroralna suspenzija peroralna uporaba
10 mg/kg body weight twice daily to 15 mg/kg body weight twice daily with a maximum of 500 mg per dose. 
10 mg/kg do 15 mg/kg telesne mase dvakrat na dan; največ 500 mg na odmerek
BEFORE YOU TAKE CIPROFLOXACIN BAYER 
Preden vzamete zdravilo Ciprofloksacin Bayer
• lung and bronchial infections in children and adolescents suffering from cystic fibrosis 
− pljučno in bronhialno poslabšanje cistične fibroze pri otrocih in mladostnikih − zapletene okužbe sečil, vključno z okužbami ledvic (pielonefritis)
10 mg/kg body weight twice daily to 15 mg/kg body weight twice daily with a maximum of 500 mg per dose, corresponding to a 0.1 mL/kg body weight twice daily to 0.15 mL/kg body weight twice daily with a maximum of 5 mL per dose 
10 mg/kg do 15 mg/kg telesne mase dvakrat na dan; največ 500 mg na odmerek kar odgovarja 0,1 ml/kg telesne mase dvakrat na dan do 0,15 ml/kg telesne mase dvakrat na dan; največ 5 ml na odmerek
500 mg/5 ml oral suspension oral use use 
500 mg/5 ml peroralna suspenzija peroralna uporaba
5 mL twice daily to 7.5 mL twice daily (one 5-mL measuring spoonful twice daily up to one and a half 5mL measuring spoonfuls twice daily) 
5 - 7,5 ml dvakrat na dan (ena do ena in pol 5-ml merilna žlička dvakrat na dan)
10 mg/kg body weight twice daily to 15 mg/kg body weight twice daily with a maximum of 500 mg per dose, corresponding to a 0.2 mL/kg body weight twice daily to 0.3 mL/kg body weight twice daily with a maximum of 10 mL per dose 
10 mg/kg do 15 mg/kg telesne mase dvakrat na dan; največ 500 mg na odmerek kar odgovarja 0,2 ml/kg telesne mase dvakrat na dan do 0,3 ml/kg telesne mase dvakrat na dan; največ 10 ml na odmerek
50 mg/ml oral suspension oral use 
50 mg/ml peroralna suspenzija peroralna uporaba
10 mL twice daily (two 5-mL measuring spoonfuls twice daily) 
10 ml dvakrat na dan (dve 5-ml merilni žlički dvakrat na dan)
Haemolytic anaemia Agranulocytosis Pancytopenia (lifethreatening) Bone marrow depression (lifethreatening) 
Bolezni krvi in limfatičnega sistema eozinofilija levkopenija anemija nevtropenija levkocitoza trombocitopenija trombocitemija hemolitična anemija agranulocitoza pancitopenija (smrtno nevarna) depresija kostnega mozga (smrtno
Ciprobay XR 1000 mg modified release tablets oral use 
Ciprobay XR 1000 mg tablete s prirejenim sproščanjem peroralna uporaba
10 mL twice daily to 15 mL twice daily (two 5-mL measuring spoonfuls twice daily up to three 5-mL measuring spoonfuls twice daily) 
10 - 15 ml dvakrat na dan (dve do tri 5-ml merilne žličke dvakrat na dan)
Rare side effects (between 1 and 10 in every 10,000 people are likely to get these): 
Redki (manj kot 1 od 1.000, ampak več kot 1 od 10.000 bolnikov)
Ciprobay XR 500 mg modified release tablets oral use 
Ciprobay XR 500 mg tablete s prirejenim sproščanjem peroralna uporaba
CIPROXIN 500 mg film-coated tablets oral use 
CIPROXIN 500 mg filmsko obložene tablete peroralna uporaba
100 mg film-coated tablets oral use 
100 mg filmsko obložene tablete peroralna uporaba
250 mg film-coated tablets oral use 
250 mg filmsko obložene tablete peroralna uporaba
750 mg film-coated tablets oral use 
750 mg filmsko obložene tablete peroralna uporaba
CIPROBAY 200 mg/100 ml solution for infusion intravenous use 
CIPROBAY 200 mg/100 ml raztopina za infundiranje intravenska uporaba 2 mg/ml
2.5 mL twice daily to 5 mL twice daily (half 5-mL measuring spoonful twice daily up to one 5-mL measuring spoonful twice daily) 
2,5 - 5 ml dvakrat na dan (pol do ena 5-ml merilna žlička dvakrat na dan)
Ciprofloxacin Bayer), urinary tract inflammation - fluid retention or excessive sweating - abnormal levels of a clotting factor (prothrombin) or increased levels of the enzyme amylase 
− nenormalne vrednosti faktorja strjevanja krvi (protrombin) ali zvečane vrednosti encima amilaza
CIPROXIN 100 mg/50 ml solution for infusion intravenous use 
CIPROXIN 100 mg/50 ml raztopina za infundiranje intravenska uporaba 2 mg/ml
oral use 
Način uporabe
15 mL twice daily (three 5-mL measuring spoonfuls twice daily) 
15 ml dvakrat na dan (tri 5-ml merilne žličke dvakrat na dan)
Ask your doctor or pharmacist if you are not sure how to take Ciprofloxacin Bayer. 
Ne vozite ter ne upravljajte s stroji, dokler ne veste, kako se vaše telo odziva na zdravilo Ciprofloksacin Bayer.
CIPROBAY 100 mg/50 ml solution for infusion intravenous use 
CIPROBAY 100 mg/50 ml raztopina za infundiranje intravenska uporaba 2 mg/ml
- inflammation of the bowel (colitis) linked to antibiotic use (can be fatal in very rare cases) (see 
Infekcijske in parazitske bolezni glivične okužbe kolitis, ki nastane zaradi jemanja antibiotikov (zelo redko z možnim smrtnim izidom) (glejte poglavje
CIPROXIN XR 500 mg modified release tablets oral use 
CIPROXIN XR 500 mg tablete s prirejenim sproščanjem peroralna uporaba
A 60-minute intravenous infusion of 200 mg ciprofloxacin or the oral administration of 250 mg ciprofloxacin, both given every 12 hours, produced an equivalent area under the serum concentration time curve (AUC). 
Pri 60-minutnem intravenskem infundiranju 200 mg ciprofloksacina ali po peroralni uporabi 250 mg ciprofloksacina na 12 ur je AUC enaka.
Remember to drink plenty of fluids while you are taking Ciprofloxacin Bayer. 
Med zdravljenjem z zdravilom Ciprofloksacin Bayer pijte zadostne količine tekočin.
Frequency not known (cannot be estimated from the available data) - troubles associated with the nervous system such as pain, burning, tingling, numbness and/ or weakness in extremities - severe cardiac rhythm abnormalities, irregular heart beat (Torsades de Pointes) 
− težave v povezavi z živčnim sistemom (npr. bolečina, žarenje, ščemenje, odrevenelost in/ali oslabelost okončin)
CIPROXIN 200 mg/100 ml solution for infusion intravenous use 
CIPROXIN 200 mg/100 ml raztopina za infundiranje intravenska uporaba 2 mg/ml